Kashvi Gupta, M.D., M.P.H.

I have a paper on treatment with sodium-glucose cotransporter-2 inhibitors (SGLT2i), a class of medications which has been recently shown to greatly benefit patients with a range of cardiovascular and kidney disease. As first author, my role in this project was to design the study under the guidance of my mentors, interpret the data analysis, write and revise the manuscript for publication.

• Gupta K, Spertus JA, Birmingham M, Gosch KL, Husain M, Kitzman DW, Pitt B, Shah SJ, Januzzi JL, Lingvay I, Butler J, Kosiborod M, Lanfear DE. Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials. Circulation. 2023 Jul 18;148(3):220-228. doi: 10.1161/CIRCULATIONAHA.122.063263. Epub 2023 May 16. PMCID PMC10523916

I have another paper on sleep duration and healthy eating, which is an essential component to optimizing cardiovascular-kidney-metabolic health. As first author, my role in this project was to design the study under the guidance of my mentors, prepare and clean the dataset for analysis using SAS software, analyze and interpret the results, write and revise the manuscript for publication.

• Gupta K, Jansen EC, Campos H, Baylin A. Associations between sleep duration and Mediterranean diet score in Costa Rican adults. Appetite. 2022 Mar 1;170:105881. doi: 10.1016/j.appet.2021.105881. Epub 2021 Dec 21. PMCID PMC8761173

I have participated in the conduct of randomized controlled trials. My role in these projects was ensuring regulatory compliance, patient recruitment, data management and quality control, analyzing and interpreting the data, revising manuscript for publication.

• Jeganathan VS, Golbus JR, Gupta K, Luff E, Dempsey W, Boyden T, Rubenfire M, Mukherjee B, Klasnja P, Kheterpal S, Nallamothu BK. Virtual AppLication-supported Environment To INcrease Exercise (VALENTINE) during cardiac rehabilitation study: Rationale and design. Am Heart J. 2022 Jun;248:53-62. doi: 10.1016/j.ahj.2022.02.012. Epub 2022 Feb 27.
• Golbus JR, Gupta K, Stevens R, Jeganathan VSE, Luff E, Shi J, Dempsey W, Boyden T, Mukherjee B, Kohnstamm S, Taralunga V, Kheterpal V, Murphy S, Klasnja P, Kheterpal S, Nallamothu BK. A randomized trial of a mobile health intervention to augment cardiac rehabilitation. NPJ Digit Med. 2023 Sep 14;6(1):173. doi: 10.1038/s41746-023-00921-9. PMCID PMC10502072

Ever since medical school, I have been contributing to the medical literature, initially through case reports.

• Arnautovic JZ, Mazhar A, Tereziu S, Gupta K. A Rare Association of Congenital Asplenia with Jejunal Arteriovenous Malformation. Am J Case Rep. 2017 Oct 19;18:1118-1122. doi: 10.12659/ajcr.903741. PMCID PMC5659234
• Gupta K, Stuewe E, Barry M. Asymptomatic man with an incidental finding of a massive empyema. BMJ Case Rep. 2020 Sep 10;13(9):e237178. doi: 10.1136/bcr-2020-237178. PMCID PMC7484871

During internal medicine residency, I worked under the mentorship of cardiologists and co-authored the following clinical research publications.

• Nguyen DD, Spertus JA, Kennedy KF, Gupta K, Uzendu AI, McNally BF, Chan PS. Association Between Delays in Time to Bystander CPR and Survival for Witnessed Cardiac Arrest in the United States. Circ Cardiovasc Qual Outcomes. 2024 Feb;17(2):e010116. doi: 10.1161/CIRCOUTCOMES.123.010116. Epub 2023 Dec 26. PMCID PMC10923150
• Golbus JR, Gupta K, Stevens R, Jeganathan VS, Luff E, Boyden T, Mukherjee B, Klasnja P, Kheterpal S, Kohnstamm S, Nallamothu BK. Understanding Baseline Physical Activity in Cardiac Rehabilitation Enrollees Using Mobile Health Technologies. Circ Cardiovasc Qual Outcomes. 2022 Jul;15(7):e009182. doi: 10.1161/CIRCOUTCOMES.122.009182. Epub 2022 May 13. PMCID PMC9308648